Loading data for NNNN — first visit, this takes a few seconds.
Anbio Biotechnology (NNNN)
NasdaqGM: NNNN
· Real-Time Price · USD
6.54
-0.06 (-0.91%)
At close: Sep 04, 2026, 8:00 PM
6.54
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Anbio Biotechnology (NNNN) Stock Price, Analysis & Data
No data available
| Bid | 11.55 |
| Market Cap | 287M |
| Revenue (ttm) | 8.65M |
| Net Income (ttm) | 6.4M |
| 0.00 | |
| 0.15 | |
| 43.6 | |
| n/a | |
| P/B (ttm) | 9.52 |
| P/S (ttm) | 33.20 |
| Earnings Date | n/a |
| Ask | 9.89 |
| Volume | 231,146 |
| Avg. Volume (20D) | 101,955 |
| Open | 6.58 |
| Previous Close | 6.60 |
| Day's Range | 6.36 - 6.77 |
| 52-Week Range | 6.28 - 51.33 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About NNNN
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over...
Industry Medical Instruments & Supplies
Sector Healthcare
IPO Date Feb 19, 2025
Employees 27
Stock Exchange NasdaqGM
Ticker Symbol NNNN
Financial Performance
In 2025, Anbio Biotechnology's revenue was 8.65M, an increase of 5.64% compared to the previous year's 8.19M. Earnings were 6.4M, an increase of 169.86%.
Financial StatementsEarnings Surprise
Anbio Biotechnology has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Page 1 of 2